Effective tumour necrosis factor-blocking therapy reduces reactive oxygen metabolite level in rheumatoid arthritis

OBJECTIVE: To assess circulating levels of derived reactive oxygen metabolites (ROMs) in patients with active rheumatoid arthritis (RA), before and during antitumour necrosis factor (TNF)-α therapy. METHODS: Patients with active RA and failed previous treatment with disease-modifying antirheumatic d...

Descripción completa

Detalles Bibliográficos
Autores principales: Cacciapaglia, Fabio, Grazia Anelli, Maria, Rizzo, Daniela, Morelli, Emma, Mazzotta, Daniela, Scioscia, Crescenzio, Iannone, Florenzo, Lapadula, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Gene/Molecular Research on Immune-Mediated Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536522/
https://www.ncbi.nlm.nih.gov/pubmed/27683135
http://dx.doi.org/10.1177/0300060515593227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536522/
https://www.ncbi.nlm.nih.gov/pubmed/27683135
http://dx.doi.org/10.1177/0300060515593227

Ejemplares similares